Over the course of the last few trading days, we have seen the return of volatility and some serious carnage in the markets. To kick off this week, the Dow Jones Industrial…
Theravance Biopharma shares made a solid gain on Wednesday after the company announced a global collaboration with Janssen Biotech.
Chris Lange 24/7 Wall St. is addressing some of the top market darlings and most widely held stocks by the public. We looked at how the drop was on Monday and how the shares…
24/7 Wall St. has chosen a list of companies that will operate fine in times of market turmoil and probably will operate well from financial standpoint even if economic turmoil were to…
Chevron, Exxon, 3M, and Johnson & Johnson led all 30 DJIA stocks on a second-consecutive unanimous tumble.
24/7 Wall St. has included a calendar of a some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February.
Johnson &; Johnson, Gilead Sciences and Amicus Therapeutics are among companies expecting clinical trial and FDA updates in February.
Boeing, 3M, Johnson & Johnson, and United Technologies pushed the DJIA to a triple-digit gain Thursday.
Travelers and General Electric played big roles in helping the Dow finish basically flat Monday. Johnson & Johnson and Procter & Gamble lagged after tepid quarterly results.
Johnson & Johnson reported better-than-expected fourth-quarter financial results before the markets opened on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of GE, Intel, Verizon and other Dow Jones Industrial Average companies due to report their quarterly results this week.
Boeing, General Electric, Johnson & Johnson, and United Technologies were Tuesday's pacesetters among the Dow 30 stocks.
Credit Suisse has put together a list of biopharma companies in its coverage universe that stand to make significant moves in 2018.
Here is a consensus forecast of each of the 30 Dow Jones Industrial stocks, including a forward 12-month consensus analyst price target and an expected 2018 total return on each.
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
